Clinical Trial Update: Early Access to Low-dose Ritonavir (TMC114/r) and Other Antiretrovirals (ARVs) for Treatment-naive or Early Treatment Experienced in HIV-1 Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on early access to low-dose ritonavir boosting with other antiretrovirals for treatment-naive or early-treated HIV-1 patients; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• PREZISTA (darunavir)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: HIV-1 | Phase 4 | Status: COMPLETED